Glenmark Pharmaceuticals Limited has informed the Exchange that the Board approves Dividend and as intimated earlier Record date for the purpose of Dividend is 03-Oct-2025.
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Midcap 150 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Glenmark Pharmaceuticals' Board has approved an Interim Dividend of ₹2.50 per equity share (on face value of ₹1) for FY 2025-26, totaling around ₹705.50 million. The record date for eligibility is October 3, 2025, and the dividend will be paid within 30 days of declaration. Separately, the Board reconstituted three committees — Stakeholders Relationship, Risk Management, and ESG — effective October 1, 2025, with new chairpersons and members appointed.
Shareholders on record as of October 3, 2025, will receive the ₹2.50 per share interim dividend. The ₹705.50 million payout is modest in scale and is unlikely to materially move the stock price on its own, though it signals continued shareholder returns by the company.